FAKTOR-OPTIONSSCHEIN - MIMEDX GROUP Share Price

Certificat

DE000MG23S43

Market Closed - Börse Stuttgart 20:58:44 17/05/2024 BST
8.59 EUR -9.10% Intraday chart for FAKTOR-OPTIONSSCHEIN - MIMEDX GROUP
Current month+137.29%
1 month+38.33%
Date Price Change
17/05/24 8.59 -9.10%
16/05/24 9.45 -6.44%
15/05/24 10.1 +14.64%
14/05/24 8.81 +21.02%
13/05/24 7.28 +1.25%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 08:58 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MIMEDX GROUP, INC.
Issuer Morgan Stanley
WKN MG23S4
ISINDE000MG23S43
Date issued 10/04/2024
Strike 6.314 $
Maturity Unlimited
Parity 0.16 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.38
Lowest since issue 3.04
Spread 0.13
Spread %1.49%

Company Profile

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Sector
-
More about the company

Ratings for MiMedx Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: MiMedx Group, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
7.8 USD
Average target price
12.68 USD
Spread / Average Target
+62.61%
Consensus